News

Supernus Pharmaceuticals Showcases Commitment at Neuropsychiatry Summit

Supernus Pharmaceuticals Showcases Commitment at Neuropsychiatry Summit

Supernus Pharmaceuticals Joins Neuropsychiatry Summit

Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN) is leading the way in biopharmaceutical innovation geared towards treating diseases of the central nervous system (CNS). With a strong focus on improving patient care, the company is thrilled to announce its participation in the TD Cowen 4th Annual Novel Mechanisms in Neuropsychiatry Summit. On this important day, Jack Khattar, Supernus' President and CEO, will join the event virtually, engaging in meaningful discussions about the future of CNS therapies.

Details on the Upcoming Fireside Chat

This virtual fireside chat is set for Thursday, September 26, 2024, at 8:40 a.m. ET. Khattar's presence at the summit highlights Supernus' commitment to addressing neuropsychiatric disorders. Attendees can look forward to gaining valuable insights into the company’s strategies and future plans for developing innovative therapies aimed at CNS conditions.

How to Access the Live Webcast

If you're interested in following the discussions, you'll be able to watch a live webcast. You can easily access it through Supernus Pharmaceuticals' official website, making sure that stakeholders can stay up-to-date on the latest developments in neuropsychiatry and Supernus' contributions to this vital field.

Supernus' Product Portfolio and Commitment to CNS Care

Supernus Pharmaceuticals features a diverse product portfolio targeting key areas within the CNS landscape. Their current offerings include effective treatments for conditions such as epilepsy, migraines, ADHD, and more. Moreover, the company is actively working to address complex challenges like hypomobility related to Parkinson's disease and other CNS disorders, showcasing their relentless drive for medical innovation.

Focus on Research and Development

The company is in the process of developing new therapies that hold significant promise for improving patients' lives. As they expand their offerings, Supernus is committed to delivering safe and effective treatments aligned with patients' ever-changing needs. With robust clinical trials and extensive research, the organization is determined to find and introduce groundbreaking solutions for neurological health.

Core Philosophy and Vision

Supernus Pharmaceuticals operates with a core philosophy centered on enhancing patient outcomes. The leadership team believes that investing in innovative research and focusing on patient care can make a meaningful difference in the healthcare community. Their dedication to improving the quality of life for those battling CNS-related conditions drives their ongoing work and collaboration throughout the industry.

Looking Ahead: The Future of Supernus Pharmaceuticals

The outlook for Supernus is bright as the company continues to explore new avenues in CNS treatment. With various projects underway, stakeholders can expect a range of promising developments that will enhance their already impressive product lineup. As they progress, Supernus remains dedicated to meeting unmet medical needs and ensuring that innovative treatment options are readily available to those in need.

Contact Information

If you have any further questions, please reach out to the Supernus Pharmaceuticals team:

Jack A. Khattar, President and CEO
Timothy C. Dec, Senior Vice President and CFO
Phone: (301) 838-2591

You can also contact Peter Vozzo
ICR Westwicke
Phone: (443) 213-0505
Email: peter.vozzo@westwicke.com

Frequently Asked Questions

What is Supernus Pharmaceuticals' main focus?

Supernus Pharmaceuticals is committed to developing and commercializing products for the treatment of CNS diseases.

When will the summit take place?

The TD Cowen 4th Annual Novel Mechanisms in Neuropsychiatry Summit is scheduled for September 26, 2024.

Who will represent Supernus at the summit?

Jack Khattar, the President and CEO, will represent Supernus Pharmaceuticals in a fireside chat.

How can I watch the live presentation?

The live webcast can be accessed through the Supernus Pharmaceuticals website on the day of the event.

What types of treatments does Supernus Pharmaceuticals offer?

Supernus offers treatments for epilepsy, migraines, ADHD, and several other CNS conditions.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

West Virginia Water's $850K Upgrade: A Local Boost

Updated Category News Views 150

$850,000 For Aging Pipes: A Long-Needed Move Picture a dusty road in West Virginia—Old Route 38. Now, imagine it bustling with work crews hustling to give the town’s water infrastructure a much-needed facelift. West Virginia American Water is laying down $850,000 to replace 3,500 feet of worn-out pipe with durable PVC, aiming to curb service outages and ensure...

Continue Reading
Coastal Financial Faces Class Action Suit Over Securities

Updated Category News Views 22

Securities Law Tangles: Coastal Financial Hits a Snag There's no dodging it—Coastal Financial Corporation's dogged by a class action lawsuit, and investors need to sit up and take notice. This kind of legal fracas can hit the stock price like a brick through a window, especially when alleged securities law violations crop up. DJS Law Group's got the reins on this one,...

Continue Reading
Viatris Declares Quarterly Dividend Amid Acquisition Buzz

Updated Category News Views 79

A Dividend Declaration with a Side of Mergers Viatris, the healthcare giant operating on a global scale, has been making some noise recently. On the surface, it's another quarterly dividend—$0.12 per share, set to hit the pockets of shareholders on December 16. But there's a lot more cooking under the hood of this announcement that ticks just about every box for a...

Continue Reading
Dissecting the USDOT's New DBE/ACDBE Final Rule

Updated Category News Views 155

The Landscape Shift in DBE/ACDBE Compliance When the USDOT decided to roll out their Final Rule in September, they didn't just shuffle the deck - they reshuffled the whole game for the Disadvantaged Business Enterprise (DBE) and Airport Concession Disadvantaged Business Enterprise (ACDBE) programs. Public agencies and businesses from coast to coast have been left...

Continue Reading
Compass Datacenters Welcomes Texas Governor-Elect Hinojosa

Updated Category News Views 59

The Data Game in Texas Just Got Interesting Today's headlines aren't short of drama, but here's one that's got my attention. Compass Datacenters is casting a hopeful eye toward the incoming Texas Governor, Hinojosa. It's a name to remember—not just for politicos but for anyone with a thumb in the data pie. As these folks see it, Hinojosa's election isn't just about...

Continue Reading
NNB Nutrition Unveils Revolutionary Ingredient Advances

Updated Category News Views 60

Sweet Innovation in a Natural Package Gotta hand it to NNB Nutrition—they’re not just shaking things up; they’re blending it into a whole new flavor universe. At the SupplySide Global 2026 in Vegas, NNB threw down some hefty advancements that might make even ol' Rockefeller sit up and take notice. We're talking about SweetVantage®, their brand-new creation that's...

Continue Reading
GomSpace Targets SEK 1.6 Billion Revenue by 2030

Updated Category News Views 90

GomSpace's Bold Ambition for 2030 The small satellite sector just got a wake-up call from GomSpace. This company has its eyes locked on a jaw-dropping SEK 1.6 billion in revenue by 2030. That's not just some pie-in-the-sky dream. GomSpace is gunning for a calculated annual growth of 30%, riding high on revamped operations and a mighty push into big, juicy contract...

Continue Reading
CMS Fee Adjustments Aid Orthopaedics, But Issues Stay

Updated Category News Views 47

A Partial Win for Orthopaedic Care Access This week, we’ve got a sigh of relief rolling through the orthopaedic corridors with the Centers for Medicare & Medicaid Services (CMS) dialing back on its proposed fee cuts. You’d think they were about to pull the rug out from beneath procedures most patients can't afford to get scarce. It’s not a full victory, but...

Continue Reading
DraftKings Faces Scrutiny Over AI Use in Promotions

Updated Category News Views 61

DraftKings Under the Legal Microscope So here's a doozy that’s rattling through Beantown: DraftKings, the sportsbook titan, might be walking on financial eggshells thanks to their bold use of artificial intelligence. Shapiro Haber & Urmy, a doughty Boston legal jockey, is giving the high sign to users about a consumer class action investigation involving DraftKings'...

Continue Reading
Kate Spade Unveils Festive 2026 Holiday Campaign

Updated Category News Views 69

Kate Spade's Bold Holiday Blitz Ah, holiday campaigns. They’re like the department store windows of the digital age—bursting with color, life, and a hint of commercial frenzy. And Kate Spade New York’s 2026 holiday campaign? Well, it’s certainly making waves. Featuring a crew of high-profile creators, this campaign unfolds like a lavish NYC holiday party—styled...

Continue Reading

Top 5 Most Recently Viewed Articles

Introducing Cove Investments' Innovative Debt-Free Portfolio

Updated Category News Views 135

Innovative Investment Opportunity from Cove Capital Investments This latest DST offering showcases a remarkable diversified portfolio designed to cater to various investors, emphasizing its geographical coverage, asset classes, and notable tenant companies. The potential for significant income through ACH Direct Deposit is a compelling factor for many. Acquisition of...

Continue Reading
Hydrogen Truck Market Predicted to Approach $171 Billion by 2034

Updated Category News Views 107

The Promising Growth of the Hydrogen Truck Market As populations grow and environmental concerns surge, the transportation industry is evolving rapidly. Notably, the global hydrogen truck market is set to see an extraordinary increase, with projections indicating it could grow to nearly USD 171,050 million by 2034, representing a stunning compound annual growth rate...

Continue Reading
BofA Boosts Alphabet's Price Target Amid Cloud Expansion

Updated Category News Views 141

BofA Boosts Alphabet's Price Target Amid Cloud Expansion BofA Securities has recently updated its outlook on Alphabet Inc. (NASDAQ: GOOGL), raising the price target from $206 to $210. This decision follows Alphabet's latest revenue report, which was notably impressive. Financial Highlights from Alphabet's Quarter The company reported a remarkable net revenue of $74.5...

Continue Reading
Understanding Recent Share Transactions by Directors at DEC

Updated Category News Views 153

Insights into Recent Director Transactions Diversified Energy Company PLC (LSE: DEC) (NYSE: DEC) has seen some notable trading activity among its board members. Recently, key figures within the company made significant transactions in the ordinary shares, reflecting their confidence in the company's future prospects. Board Member Transactions Overview In a spirited...

Continue Reading
BroadForward Partners with JCI for Next-Gen Mobile Services

Updated Category News Views 474

BroadForward's Innovative Solutions for Enhanced Connectivity BroadForward, a prominent name in intelligent signaling software, has partnered with Japan Communications Inc. (TSE Prime: 9424), a leading MVNO innovator, to implement key signaling solutions. This collaboration aims to facilitate the launch of JCI's "Neo-Carrier" service by leveraging advanced technologies...

Continue Reading